|
On Monday 21 March, the Expert Review Committees of the International Union Against Cancer selected 19 Fellows for awards of almost $600,000 under three of its fellowship schemes
Geneva, Switzerland (24 March 2005) - Nineteen new Fellows this week joined over 4,000 cancer professionals who have already benefited from UICC's international cancer fellowships.
The awards made on Monday 21 March included four UICC Translational Cancer Research Fellowships, nine American Cancer Society UICC International Fellowships for Beginning Investigators, and six UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants. They range in value from $7,000 to $55,5000 and amount in total to $590,698.
The Translational Cancer Research Fellowships, sponsored by the National Cancer Institute (USA) and Novartis Oncology, aim to accelerate the translation of new-found biological understanding of cancer from the research laboratory to the patient in the clinic and to incorporate rational prevention strategies into mainstream healthcare practice.
In response to UICC's focus on prevention and as a mark of its own commitment, the National Cancer Institute decided this year to fund two additional prevention-oriented translational research projects.
"NCI is pleased to join UICC in supporting these two additional awards," said Dr Joe Harford, director of the NCI office of international affairs.
"Through discovery, development and delivery of effective cancer prevention interventions, much of the suffering and death due to cancer can be eliminated."
The ACS International Fellowships for Beginning Investigators, sponsored by the American Cancer Society, are intended to advance the development of beginning investigators and clinicians in the early stages of their academic careers.
The UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants, sponsored by the Japan National Committee for UICC, Kyowa Hakko Kogyo Company, and Toray Industries are awarded twice yearly to appropriately qualified and experienced cancer investigators engaged in bilateral research projects with institutes abroad.
The new Fellows
UICC Translational Cancer Research Fellowships
1. Dr Anders Bjartell (Sweden/USA), "Evaluation of tissue markers to predict outcome in prostate cancer"
2. Dr Rafal Dziadziusko (Poland/USA), "Predictive markers for sensitivity to EGFR inhibitors in lung cancer"
3. Dr Lee Byeong-jae (South Korea/USA), "Role of selenoproteins in cancer prevention"
4. Dr Yosef Shiloh (Israel/USA), "Dissection of the DNA damage response by genetic manipulations in the mouse"
 For a full list of Fellows, click here.
ACS International Fellowships for Beginning Investigators
1. Dr Thomas Aloia (USA/France), "Development of a Markov decision model to compare treatment strategies for patients with hepatocellular carcinoma"
2. Dr Sandrine Arnaud-Dabernat (France/USA), "FGFR3 expression and implication in pancreatic cancers"
3. Dr Antonio Feliciello (Italy/USA), "Regulation of EGF-dependent signalling by protein phosphatase PTPD1"
4. Dr Ana Gleisner (Brazil/USA), "Investigating disparities in the use of various therapies for the treatment of hepatocellular carcinoma"
5. Dr Alessandra Ianari (Italy/USA), "Physiological role of E2F1 acetylation: a gene-targeting approach"
6. Dr Marta Lomnytska (Ukraine/Sweden), "Proteomics-based study of breast cancer-associated phosphoproteins as potential diagnostic markers"
7. Dr Doron Melamed (Israel/USA), "Role of class switch recombination in the occurrence of chromosomal translocation"
8. Dr Larysa Voskoboynyk (Ukraine/Italy), "Expression of the RET proto-oncogene in post-Chernobyl thyroid tumours and uniiradiated controls"
9. Dr Ye Weimin (Sweden/USA), "Identification of high-risk group for stomach cancer"
For a full list of Fellows, click here.
UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants
1. Dr Jeffrey Gerst (Israel/Canada), "Targeting and localisation of polarity factor mRNAs in invasive tumour cells"
2. Dr Jose Martinez-Climent (Spain/USA), "Comparative genomic hybridisation to BAC microarrays in mantle cell lymphoma: identification of novel target genes and application in clinical diagnostics"
3. Dr Daniel Altschuler (USA/Italy), "Real-time FRET-based imaging of Rap1 activation"
4. Dr Tapas Kundu (India/Japan), "Visualisation and characterisation of the alteration of chromatin structure by nonhistone chromatin-associated proteins and HAT modulators"
5. Dr Martina Vockerodt (Germany/UK), "Role of LMP1 in the development of Hodgkin's lymphoma"
6. Dr Jia Weihua (China/USA), "Gene-gene interaction in nasopharyngeal carcinoma"
For a full list of Fellows, click here.
For more on Fellowships and Training, click here.
About the International Union Against Cancer (UICC)
Founded in 1933, UICC is the only international non-governmental organization dedicated exclusively to the global control of cancer. Its vision is of a world where cancer is eliminated as a major life-threatening disease. Uniting 265 cancer-fighting organizations in 84 countries, UICC is a resource for action and a voice for change. UICC represents a wide range of organizations that are engaged in the global campaign against cancer including voluntary cancer societies, research and treatment centres, public health authorities, patient support networks and advocacy groups.
|
uicc | international union against cancer 
